Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).

Goéré D, Pignon JP, Gelli M, Elias D, Benhaim L, Deschamps F, Caramella C, Boige V, Ducreux M, de Baere T, Malka D.

BMC Cancer. 2018 Aug 6;18(1):787. doi: 10.1186/s12885-018-4697-7.

2.

Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect?

Gelli M, Huguenin JFL, de Baere T, Benhaim L, Mariani A, Boige V, Malka D, Sourouille I, Ducreux M, Elias D, Goéré D.

Eur J Cancer. 2018 Sep;100:94-103. doi: 10.1016/j.ejca.2018.04.015. Epub 2018 Jul 5.

PMID:
30014885
3.

Peritoneal Metastases from Colorectal Cancer: Treatment Principles and Perspectives.

Goéré D, Sourrouille I, Gelli M, Benhaim L, Faron M, Honoré C.

Surg Oncol Clin N Am. 2018 Jul;27(3):563-583. doi: 10.1016/j.soc.2018.02.011. Review.

PMID:
29935690
4.

Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO).

Zaanan A, Bouché O, Benhaim L, Buecher B, Chapelle N, Dubreuil O, Fares N, Granger V, Lefort C, Gagniere J, Meilleroux J, Baumann AS, Vendrely V, Ducreux M, Michel P; Thésaurus National de Cancérologie Digestive (TNCD).

Dig Liver Dis. 2018 Aug;50(8):768-779. doi: 10.1016/j.dld.2018.04.025. Epub 2018 Jun 6. Review.

PMID:
29886081
5.

Model predicting the ypN0 status after good response to chemoradiotherapy in rectal cancer.

Dumont F, Dartigues P, Delga B, Thibaudeau E, Benhaim L, Campion L, Mosnier JF, Raimbourg J, Kerdraon O, Goéré D.

Am J Surg. 2018 Mar 31. pii: S0002-9610(17)31666-5. doi: 10.1016/j.amjsurg.2018.03.025. [Epub ahead of print]

PMID:
29656991
6.

Radiofrequency ablation for colorectal cancer liver metastases initially greater than 25 mm but downsized by neo-adjuvant chemotherapy is associated with increased rate of local tumor progression.

Benhaim L, El Hajjam M, Malafosse R, Sellier J, Julie C, Beauchet A, Nordlinger B, Peschaud F.

HPB (Oxford). 2018 Jan;20(1):76-82. doi: 10.1016/j.hpb.2017.08.023. Epub 2017 Oct 10.

PMID:
29029986
7.

Conversion to Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma After Bidirectional Chemotherapy.

Le Roy F, Gelli M, Hollebecque A, Honoré C, Boige V, Dartigues P, Benhaim L, Malka D, Ducreux M, Elias D, Goéré D.

Ann Surg Oncol. 2017 Nov;24(12):3640-3646. doi: 10.1245/s10434-017-6033-x. Epub 2017 Aug 28.

PMID:
28849389
8.

Ninety percent of the adverse outcomes occur in 10% of patients: can we identify the populations at high risk of developing peritoneal metastases after curative surgery for colorectal cancer?

Honoré C, Gelli M, Francoual J, Benhaim L, Elias D, Goéré D.

Int J Hyperthermia. 2017 Aug;33(5):505-510. doi: 10.1080/02656736.2017.1306119. Review.

PMID:
28540831
9.

[Factors affecting the choice of peritoneal dialysis: Perspective of patients and nephrologists].

Habib A, Durand AC, Brunet P, Duval-Sabatier A, Moranne O, Bataille S, Benhaim L, Bargas É, Gentile S.

Nephrol Ther. 2017 Apr;13(2):93-102. doi: 10.1016/j.nephro.2016.07.451. Epub 2017 Feb 1. French.

PMID:
28161262
10.

Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer.

Gelli M, Huguenin JF, Cerebelli C, Benhaim L, Honoré C, Elias D, Goéré D.

Future Oncol. 2017 Apr;13(10):907-918. doi: 10.2217/fon-2016-0389. Epub 2017 Jan 5. Review.

PMID:
28052691
11.

Long-term survival after aggressive treatment of relapsed serosal or distant pseudomyxoma peritonei.

Delhorme JB, Honoré C, Benhaim L, Dumont F, Dartigues P, Dromain C, Ducreux M, Elias D, Goéré D.

Eur J Surg Oncol. 2017 Jan;43(1):159-167. doi: 10.1016/j.ejso.2016.08.021. Epub 2016 Sep 2.

PMID:
27646440
12.

Single-port endoscopic mesocolic and mesorectal excision using an extraperitoneal approach.

Dumont F, Thibaudeau E, Benhaïm L, Gouy S, Labbe D, Honoré C, Goéré D.

Surg Endosc. 2017 Jan;31(1):469-475. doi: 10.1007/s00464-016-4955-1. Epub 2016 May 3.

PMID:
27142439
13.

Huge pseudomyxoma peritonei: Surgical strategies and procedures to employ to optimize the rate of complete cytoreductive surgery.

Benhaim L, Honoré C, Goéré D, Delhorme JB, Elias D.

Eur J Surg Oncol. 2016 Apr;42(4):552-7. doi: 10.1016/j.ejso.2016.01.015. Epub 2016 Feb 1.

PMID:
26868165
14.

Laparoscopic single port pseudo-continent perineal colostomy.

Dumont F, Goéré D, Benhaim L, Honoré C, Elias D.

J Visc Surg. 2016 Feb;153(1):45-53. doi: 10.1016/j.jviscsurg.2015.10.008. Epub 2016 Jan 29. No abstract available.

PMID:
26830381
15.

Peritoneal carcinomatosis from unusual cancer origins: Is there a role for hyperthermic intraperitoneal chemotherapy?

Honoré C, Goéré D, Macovei R, Colace L, Benhaim L, Elias D.

J Visc Surg. 2016 Apr;153(2):101-7. doi: 10.1016/j.jviscsurg.2015.11.010. Epub 2015 Dec 11.

PMID:
26698380
16.

Can a Benefit be Expected from Surgical Debulking of Unresectable Pseudomyxoma Peritonei?

Delhorme JB, Elias D, Varatharajah S, Benhaim L, Dumont F, Honoré C, Goéré D.

Ann Surg Oncol. 2016 May;23(5):1618-24. doi: 10.1245/s10434-015-5019-9. Epub 2015 Dec 17.

PMID:
26678404
17.

Laparoscopic Versus Open Surgery for Gastric Gastrointestinal Stromal Tumors: What Is the Impact on Postoperative Outcome and Oncologic Results?

Piessen G, Lefèvre JH, Cabau M, Duhamel A, Behal H, Perniceni T, Mabrut JY, Regimbeau JM, Bonvalot S, Tiberio GA, Mathonnet M, Regenet N, Guillaud A, Glehen O, Mariani P, Denost Q, Maggiori L, Benhaim L, Manceau G, Mutter D, Bail JP, Meunier B, Porcheron J, Mariette C, Brigand C; AFC and the FREGAT working group.

Ann Surg. 2015 Nov;262(5):831-9; discussion 829-40. doi: 10.1097/SLA.0000000000001488.

PMID:
26583673
18.

Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix.

Honoré C, Caruso F, Dartigues P, Benhaim L, Chirica M, Goéré D, Elias D.

Anticancer Res. 2015 Sep;35(9):4943-7.

PMID:
26254392
19.

Linear Relationship of Peritoneal Cancer Index and Survival in Patients with Peritoneal Metastases from Colorectal Cancer.

Faron M, Macovei R, Goéré D, Honoré C, Benhaim L, Elias D.

Ann Surg Oncol. 2016 Jan;23(1):114-9. doi: 10.1245/s10434-015-4627-8. Epub 2015 May 27.

PMID:
26014158
20.

Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer.

Bohanes P, Yang D, Loupakis F, LaBonte MJ, Gerger A, Ning Y, Lenz C, Lenz F, Wakatsuki T, Zhang W, Benhaim L, El-Khoueiry A, El-Khoueiry R, Lenz HJ.

Pharmacogenomics J. 2015 Jun;15(3):226-34. doi: 10.1038/tpj.2014.66. Epub 2014 Dec 9.

PMID:
25487679
21.

Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer.

Benhaim L, Zhang W, Wakatsuki T, Yang D, Gerger A, Bohanes P, Paez D, Loupakis F, LaBonte MJ, Ning Y, El-Khoueiry R, Ladner R, Wilson P, Zhang H, Giamas G, Stebbing J, Lenz HJ.

Pharmacogenomics J. 2015 Jun;15(3):235-40. doi: 10.1038/tpj.2014.58. Epub 2014 Oct 7.

PMID:
25287073
22.

ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma.

Laforest A, Aparicio T, Zaanan A, Silva FP, Didelot A, Desbeaux A, Le Corre D, Benhaim L, Pallier K, Aust D, Pistorius S, Blons H, Svrcek M, Laurent-Puig P.

Eur J Cancer. 2014 Jul;50(10):1740-6. doi: 10.1016/j.ejca.2014.04.007. Epub 2014 May 2.

PMID:
24797764
23.

Prospective study of EGFR intron 1 (CA)n repeats variants as predictors of benefit from cetuximab and irinotecan in chemo-refractory metastatic colorectal cancer (mCRC) patients.

Loupakis F, Antoniotti C, Cremolini C, Zhang W, Yang D, Wakatsuki T, Bohanes P, Schirripa M, Salvatore L, Masi G, Ricci V, Graziano F, Ruzzo A, Benhaim L, Marmorino F, Ning Y, El-Khoueiry R, Falcone A, Lenz HJ.

Pharmacogenomics J. 2014 Aug;14(4):322-7. doi: 10.1038/tpj.2014.1. Epub 2014 Feb 11.

PMID:
24513691
24.

Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients.

Taly V, Pekin D, Benhaim L, Kotsopoulos SK, Le Corre D, Li X, Atochin I, Link DR, Griffiths AD, Pallier K, Blons H, Bouché O, Landi B, Hutchison JB, Laurent-Puig P.

Clin Chem. 2013 Dec;59(12):1722-31. doi: 10.1373/clinchem.2013.206359. Epub 2013 Aug 12.

25.

Prospective validation of candidate SNPs of VEGF/VEGFR pathway in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab.

Loupakis F, Cremolini C, Yang D, Salvatore L, Zhang W, Wakatsuki T, Bohanes P, Schirripa M, Benhaim L, Lonardi S, Antoniotti C, Aprile G, Graziano F, Ruzzo A, Lucchesi S, Ronzoni M, De Vita F, Tonini G, Falcone A, Lenz HJ.

PLoS One. 2013 Jul 4;8(7):e66774. doi: 10.1371/journal.pone.0066774. Print 2013.

26.

Gender-specific profiling in SCN1A polymorphisms and time-to-recurrence in patients with stage II/III colorectal cancer treated with adjuvant 5-fluoruracil chemotherapy.

Benhaim L, Gerger A, Bohanes P, Paez D, Wakatsuki T, Yang D, Labonte MJ, Ning Y, El-Khoueiry R, Loupakis F, Zhang W, Laurent-Puig P, Lenz HJ.

Pharmacogenomics J. 2014 Apr;14(2):135-41. doi: 10.1038/tpj.2013.21. Epub 2013 Jun 11.

PMID:
23752739
27.

Surgery: Cetuximab--an option for unresectable CRC liver metastases.

Laurent-Puig P, Benhaim L.

Nat Rev Clin Oncol. 2013 Jul;10(7):374-5. doi: 10.1038/nrclinonc.2013.93. Epub 2013 Jun 4. No abstract available.

PMID:
23736647
28.

A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin.

Damiano M, Diguet E, Malgorn C, D'Aurelio M, Galvan L, Petit F, Benhaim L, Guillermier M, Houitte D, Dufour N, Hantraye P, Canals JM, Alberch J, Delzescaux T, Déglon N, Beal MF, Brouillet E.

Hum Mol Genet. 2013 Oct 1;22(19):3869-82. doi: 10.1093/hmg/ddt242. Epub 2013 May 29.

29.

The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.

Absenger G, Benhaim L, Szkandera J, Zhang W, Yang D, Labonte MJ, Pichler M, Stotz M, Samonigg H, Renner W, Gerger A, Lenz HJ.

Pharmacogenomics J. 2014 Apr;14(2):130-4. doi: 10.1038/tpj.2013.15. Epub 2013 Apr 9.

PMID:
23567490
30.

Placement of an arterial hepatic catheter after a major hepatectomy for colorectal liver metastases: is this safe?

Benhaim L, Goéré D, Deschamps F, Dumont F, Bonnet S, Honoré C, Malka D, Boige V, De Baere T, Elias D.

Eur J Surg Oncol. 2013 Jun;39(6):640-7. doi: 10.1016/j.ejso.2013.02.002. Epub 2013 Mar 13.

PMID:
23490333
31.

[Patient education: state of the art of the programs in the region of Provence-Alpes-Côte d'Azur in 2008 before the publication of official documents relative to the authorizations of the Regional Health Agency (ARS)].

Parron S, Gentile S, Enel P, Benhaïm L, Ferrandino J, Bentz L, Sambuc R.

Rev Epidemiol Sante Publique. 2013 Feb;61(1):57-65. doi: 10.1016/j.respe.2012.06.403. Epub 2013 Jan 29. French.

PMID:
23374985
32.

Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.

Goéré D, Benhaim L, Bonnet S, Malka D, Faron M, Elias D, Lefèvre JH, Deschamps F, Dromain C, Boige V, Dumont F, De Baere T, Ducreux M.

Ann Surg. 2013 Jan;257(1):114-20. doi: 10.1097/SLA.0b013e31827b9005.

PMID:
23235397
33.

Ovarian metastasis is associated with retroperitoneal lymph node relapses in women treated for colorectal peritoneal carcinomatosis.

Eveno C, Goéré D, Dartigues P, Honoré C, Dumont F, Tzanis D, Benhaim L, Malka D, Elias D.

Ann Surg Oncol. 2013 Feb;20(2):491-6. doi: 10.1245/s10434-012-2623-9. Epub 2012 Sep 7.

PMID:
22956066
34.

Selecting the best targeted agent in first-line treatment of unresectable liver metastases from colorectal cancer: does the bench have the answers?

Benhaim L, Loupakis F, Labonte MJ, Lenz HJ.

J Hepatobiliary Pancreat Sci. 2012 Sep;19(5):528-35. doi: 10.1007/s00534-012-0526-6. Review.

PMID:
22735932
35.

Influence of sex on the survival of patients with esophageal cancer.

Bohanes P, Yang D, Chhibar RS, Labonte MJ, Winder T, Ning Y, Gerger A, Benhaim L, Paez D, Wakatsuki T, Loupakis F, El-Khoueiry R, Zhang W, Lenz HJ.

J Clin Oncol. 2012 Jun 20;30(18):2265-72. doi: 10.1200/JCO.2011.38.8751. Epub 2012 May 14.

36.

The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models.

Ning Y, Labonte MJ, Zhang W, Bohanes PO, Gerger A, Yang D, Benhaim L, Paez D, Rosenberg DO, Nagulapalli Venkata KC, Louie SG, Petasis NA, Ladner RD, Lenz HJ.

Mol Cancer Ther. 2012 Jun;11(6):1353-64. doi: 10.1158/1535-7163.MCT-11-0915. Epub 2012 Mar 5.

37.

Pharmacogenomics and metastatic colorectal cancer: current knowledge and perspectives.

Benhaim L, Labonte MJ, Lenz HJ.

Scand J Gastroenterol. 2012 Mar;47(3):325-39. doi: 10.3109/00365521.2012.640832. Epub 2011 Dec 19. Review.

PMID:
22182673
38.

Salvage colectomy for endoscopically removed malignant colon polyps: is it possible to determine the optimal number of lymph nodes that need to be harvested?

Benhaim L, Benoist S, Bachet JB, Julié C, Penna C, Nordlinger B.

Colorectal Dis. 2012 Jan;14(1):79-86. doi: 10.1111/j.1463-1318.2011.02533.x.

PMID:
22145739
39.

The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer.

Labonte MJ, Wilson PM, Yang D, Zhang W, Ladner RD, Ning Y, Gerger A, Bohanes PO, Benhaim L, El-Khoueiry R, El-Khoueiry A, Lenz HJ.

Ann Oncol. 2012 Jun;23(6):1455-64. doi: 10.1093/annonc/mdr445. Epub 2011 Oct 11.

40.

Common cancer stem cell gene variants predict colon cancer recurrence.

Gerger A, Zhang W, Yang D, Bohanes P, Ning Y, Winder T, LaBonte MJ, Wilson PM, Benhaim L, Paez D, El-Khoueiry R, El-Khoueiry A, Kahn M, Lenz HJ.

Clin Cancer Res. 2011 Nov 1;17(21):6934-43. doi: 10.1158/1078-0432.CCR-11-1180. Epub 2011 Sep 14.

41.

Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

Gerger A, El-Khoueiry A, Zhang W, Yang D, Singh H, Bohanes P, Ning Y, Winder T, Labonte MJ, Wilson PM, Benhaim L, Paez D, El-Khoueiry R, Absenger G, Lenz HJ.

Clin Cancer Res. 2011 Sep 1;17(17):5783-92. doi: 10.1158/1078-0432.CCR-11-1115. Epub 2011 Jul 26.

42.

Vascular endothelial growth factor receptor 3 directly regulates murine neurogenesis.

Calvo CF, Fontaine RH, Soueid J, Tammela T, Makinen T, Alfaro-Cervello C, Bonnaud F, Miguez A, Benhaim L, Xu Y, Barallobre MJ, Moutkine I, Lyytikkä J, Tatlisumak T, Pytowski B, Zalc B, Richardson W, Kessaris N, Garcia-Verdugo JM, Alitalo K, Eichmann A, Thomas JL.

Genes Dev. 2011 Apr 15;25(8):831-44. doi: 10.1101/gad.615311.

43.

Portal vein occlusion prior to extensive resection in colorectal liver metastasis: a necessity rather than an option!

Belghiti J, Benhaïm L.

Ann Surg Oncol. 2009 May;16(5):1098-9. doi: 10.1245/s10434-009-0379-7. Epub 2009 Feb 25. No abstract available.

PMID:
19241109
44.

[Elective laparoscopic colectomy in uncomplicated diverticulitis: when should surgery be performed].

Chouillard E, Benhaim L, Ata T, Etienne JC, Ghiles E, Fingerhut A.

Cir Esp. 2007 Apr;81(4):207-12. Spanish.

45.

Laparoscopic two-stage left colonic resection for patients with peritonitis caused by acute diverticulitis.

Chouillard E, Maggiori L, Ata T, Jarbaoui S, Rivkine E, Benhaim L, Ghiles E, Etienne JC, Fingerhut A.

Dis Colon Rectum. 2007 Aug;50(8):1157-63.

PMID:
17294319
46.

[Analysis of bone-implant stress distribution. Finite element modeling].

Valentin I, Taieb A, Benhaim L, Franquin JC, Houri A.

Cah Prothese. 1990 Dec;(72):142-53. French.

PMID:
2268785
47.

[Infrared telethermometry measuring method for temperature elevations in implantology].

Franquin JC, Taieb A, Benhaim L, Chezeaux JC, Bismuth W.

Inf Dent. 1989 Jun 15;71(24):2083-92. French. No abstract available.

PMID:
2630490
48.

[Research in implantology].

Benhaim L.

Rev Odontoimplantol. 1974 May-Jun;6(52):3-5. French. No abstract available.

PMID:
4530440
49.

[Realities and prospectives in implantology].

Benhaim L.

Inf Dent. 1972 Feb 24;54(8):709-11. French. No abstract available.

PMID:
4501830
50.

[Periodontal membrane and peri-implant supporting tissues].

Benhaim L.

Promot Dent. 1972;(17):11-2 passim. French. No abstract available.

PMID:
4511523

Supplemental Content

Loading ...
Support Center